Mycobacterium tuberculosis is ready to colonize, persist, and massively replicate in host cells, resembling phagocytes and epithelial cells. The intracellular stage of the micro organism is important to the event of tuberculosis pathogenesis. The detailed mechanisms of intracellular trafficking of the bacillus will not be totally understood and require additional investigations.
Therefore, rising the information of this course of will assist to develop therapeutic instruments that may decrease the burden of tuberculosis. M. tuberculosis is genetically tractable and tolerates the expression of heterologous fluorescent proteins. Thus, the intracellular distribution of the micro organism expressing fluorescent tracers will be simply outlined utilizing confocal microscopy.
Advances in imaging methods and images-based evaluation permit the speedy quantification of organic objects in advanced environments. In this chapter, we detailed high-content / high-throughput imaging strategies to trace the bacillus inside host cell settings.
Oligo-Mediated Recombineering and its Use for Making SNPs, Knockouts, Insertions, and Fusions in Mycobacterium tuberculosis
Phage recombination techniques have been instrumental within the growth of gene modification applied sciences for bacterial pathogens. In specific, the Che9 phage RecET system has been used efficiently for over 10 years for making gene knockouts and fusions in Mycobacterium tuberculosis. This “recombineering” expertise sometimes makes use of linear dsDNA substrates that comprise a drug-resistance marker flanked by (as much as) 500 base pairs of DNA homologous to the goal website.
Less usually employed in mycobacterial recombineering is the use of oligonucleotides, which require solely the motion of the RecT annealase to align oligos to ssDNA areas of the replication fork, for subsequent incorporation into the chromosome. Despite the upper frequency of such occasions relative to dsDNA-promoted recombineering, oligo-mediated adjustments typically endure from the drawback of not being selectable, thus making them more durable to isolate.
This chapter discusses steps and methodologies that improve the frequencies of discovering oligo-mediated occasions, together with the switch of single nucleotide polymorphisms (SNPs) to mycobacterial chromosomes, and the use of oligos along side the mycobacterial phage Bxb1 site-specific recombination system for the straightforward era of knockouts, insertion, and fusions, in a protocol generally known as ORBIT.
Reduced thyroxine manufacturing in younger family contacts of tuberculosis sufferers will increase energetic tuberculosis illness danger
In the present examine, we adopted 839 family contacts (HHCs) of tuberculosis (TB) sufferers for two years and recognized the elements that enhanced the event of TB. Fourteen of the 17 HHCs who progressed to TB had been within the 15- to 30-year-old age group. At baseline (the “0” time level, when all of the people had been wholesome), the focus of the thyroid hormone thyroxine (T4) was decrease, and there have been elevated numbers of Tregs in PBMCs of TB progressors.
At baseline, PBMCs from TB progressors stimulated with early secretory antigenic goal 6 (ESAT-6) and 10 kDa tradition filtrate antigen (CFP-10) produced much less IL-1α. Thyroid hormones inhibited Mycobacterium tuberculosis (Mtb) progress in macrophages in an IL-1α-dependent method. Mtb-infected Thra1PV/+ (mutant thyroid hormone receptor) mice had elevated mortality and decreased IL-1α manufacturing. Our findings recommend that younger HHCs who exhibit decreased manufacturing of thyroid hormones are at excessive danger of creating energetic TB illness.
Primary Eustachian Tube Tuberculosis
Nasopharyngeal tuberculosis is a uncommon incidence, and primarily entails the proximal half of the Eustachian tube. Mechanical obstruction of the Eustachian tube will have an effect on the stress discrepancy between the center ear and the exterior ambiance, resulting in aural fullness, unilateral listening to disturbance, and otitis media.
These situations will be ignored or mistakenly identified as ear pathology. We report a case of unilateral listening to loss and tinnitus in a 31-year-old wholesome lady that was later confirmed to be tuberculosis of the Eustachian tube. In circumstances with indicators suggesting a excessive index of suspicion, an intensive examination of the top and neck areas is very crucial. Once it has been identified, Eustachian tuberculosis will be efficiently handled with anti-tuberculosis drugs.
Drug Sensitivity Testing of Mycobacterium tuberculosis Growing in a Hollow Fiber Bioreactor
Hollow fiber techniques (HFSs) have been broadly utilized to check pharmacokinetic-pharmacodynamic (PK-PD) relationships in antibiotic analysis and growth. The system contains a bundle of high-density hole capillary fibers that conduct a movement of medium with or with out drug and an extra-capillary area (ECS) inoculated with the pathogen of curiosity.
The semipermeable membrane of the hole fibers permits for speedy change of small molecule medication and solutes, whereas the pathogen is restricted to the ECS. The distinctive properties of the HFS are (1) the flexibility to simulate any PK profile inside the fibers and ECS, together with plasma or site-of-disease PK profiles, (2) the flexibility to concurrently enter a number of medication with totally different half-lives, (3) the flexibility to control progress situations resembling medium composition, carbon supply, and pH, and (4) the flexibility to pattern in each compartments to be able to monitor drug concentrations and bacterial progress kinetics over time.
The system is especially suited to Mycobacterium tuberculosis analysis in a biosafety stage 3 (BSL3) atmosphere since pathogenic micro organism are sequestered in an remoted compartment. The HFS was certified by the European Medicines Agency for antituberculosis drug growth in 2015. Here, we describe the usual procedures used to check the expansion kinetics of M. tuberculosis within the HFS and the killing impact of first-line antituberculous medication utilized underneath simulated human PK situations. This animal-sparing and economical instrument will be utilized to optimize dosing schedules that reduce emergence of resistance and to prioritize drug regimens that speed up sterilization.
Exploiting Fluorescent Proteins to Understand Mycobacterium tuberculosis Biology
The utility of fluorescent proteins in bacterial analysis has lengthy been appreciated, with intensive use within the Mycobacterium tuberculosis subject. In more moderen years, a brand new era of fluorescent instruments has been developed to be used in M. tuberculosis analysis. These new fluorescent reporters exploit the immense genetic and transcriptional information now accessible, and allow the use of the micro organism as direct reporters of the native atmosphere throughout an infection, in addition to present perception into bacterial replication standing in situ.
Cancer Antigen 50 Antigen |
|||
| VAng-Cr3877-50kU | Creative Biolabs | 50 kU | EUR 6642 |
|
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|||
A549 HCP Control Antigen |
|||
| F237 | Cygnus Technologies | 50 ul | EUR 308.4 |
|
Description: A549 HCP Control Antigen by Cygnus Technologies is available in Europe via Gentaur. |
|||
Cancer Antigen 72-4 Antigen |
|||
| VAng-Cr3878-10kU | Creative Biolabs | 10 kU | EUR 505.2 |
|
Description: Cancer Antigen 72-4 Antigen, Host/Source: Metastatic Liver. The purity is ~65% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|||
Antigen 85-A Antibody (HRP) |
|||
| 20-abx109227 | Abbexa |
|
|
Antigen 85-A Antibody (FITC) |
|||
| 20-abx107809 | Abbexa |
|
|
Antigen 85-A (Ag85A) Antibody |
|||
| 20-abx110661 | Abbexa |
|
|
A549 HCP Antigen Concentrate |
|||
| F233G | Cusabio | 200 ul | EUR 540 |
|
Description: A549 HCP Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
Antigen 85-A Antibody (Biotin) |
|||
| 20-abx106397 | Abbexa |
|
|
Cancer Antigen 125 Antigen (Ascites Fluid) |
|||
| VAng-Cr3870-10kU | Creative Biolabs | 10 kU | EUR 1132.8 |
|
Description: Cancer Antigen 125 Antigen, Host/Source: Ascites Fluid. The purity is ≥ 95% by SDS-PAGE. |
|||
Cancer Antigen 125 Antigen (Human Adenocarcinoma) |
|||
| VAng-Cr3868-10kU | Creative Biolabs | 10 kU | EUR 505.2 |
|
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography. |
|||
Human carcinoembryonic antigen (CEA) antigen |
|||
| CEA15-N-100 | Alpha Diagnostics | 100 ug | EUR 270 |
HCV NS4 1916-1947aa recombinant antigen |
|||
| 00156-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HCV NS4 1916-1947aa recombinant antigen. |
|||
HCV NS4 1916-1947aa recombinant antigen |
|||
| 00156-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HCV NS4 1916-1947aa recombinant antigen. |
|||
HCV NS5 2061-2302aa recombinant antigen |
|||
| 00157-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HCV NS5 2061-2302aa recombinant antigen. |
|||
HCV NS5 2061-2302aa recombinant antigen |
|||
| 00157-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HCV NS5 2061-2302aa recombinant antigen. |
|||
HCV NS5 2212-2313aa recombinant antigen |
|||
| 00158-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. |
|||
HCV NS5 2212-2313aa recombinant antigen |
|||
| 00158-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. |
|||
HCV NS4 1916-1947aa recombinant antigen. |
|||
| 00156-V-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: HCV NS4 1916-1947aa recombinant antigen. |
|||
HCV NS5 2061-2302aa recombinant antigen. |
|||
| 00157-V-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: HCV NS5 2061-2302aa recombinant antigen. |
|||
Cancer Antigen CEA Antigen (Human Fluids) |
|||
| VAng-Wyb8644-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Carcinoembryonic Antigen, Calibrator Grade, Cancer antigen from Human Fluids, 1.13 mg/mL. |
|||
Cancer Antigen 19-9 Antigen (Liver Carcinoma) |
|||
| VAng-Cr3873-10kU | Creative Biolabs | 10 kU | EUR 472.8 |
|
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is detected by gel filtration and ion-exchange chromatography. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|||
HCV core 2-119aa recombinant antigen |
|||
| 00150-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a |
|||
HCV core 2-119aa recombinant antigen |
|||
| 00150-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a |
|||
Prostate Specific Antigen Std Grade Antigen |
|||
| VAng-Cr3891-1mg | Creative Biolabs | 1 mg | EUR 604.8 |
|
Description: Prostate Specific Antigen Std Grade Antigen, Host/Source: Human Seminal Fluid. The purity is detected by salt precipitation. |
|||
Cancer Antigen 125 Antigen (Human Adenocarcinoma) (> 90%) |
|||
| VAng-Cr3869-25kU | Creative Biolabs | 25 kU | EUR 967.2 |
|
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is> 90% by SDS-PAGE. Matched Pair: HM183, HM184, HM185, HM186. |
|||
M. Tuberculosis 85-A Antigen |
|||
| DAGA-181 | Creative Diagnostics | 100 µg | EUR 868.8 |
HBV surface recombinant antigen HBsAg antigen |
|||
| 00123-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
|||
HBV surface recombinant antigen HBsAg antigen |
|||
| 00123-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
|||
HBV surface recombinant antigen HBsAg antigen |
|||
| 00124-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
|||
HBV surface recombinant antigen HBsAg antigen |
|||
| 00124-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
|||
Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%) |
|||
| VAng-Cr3875-25kU | Creative Biolabs | 25 kU | EUR 885.6 |
|
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is> 90% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|||
Cancer Antigen AFP Antigen (Human Cord Blood) |
|||
| VAng-Wyb8624-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Alpha Fetoprotein (66 kDa), Cancer antigen from Human Cord Blood, 1.73 mg/mL. |
|||
Cancer Antigen CA-125 Antigen (Human Fluids) |
|||
| VAng-Wyb8639-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: CA-125, Calibrator Grade, cancer antigen from Human Fluids, 53.26 KU/mL. |
|||
Cancer Antigen 15-3 MUC 1 Antigen (Human Milk) |
|||
| VAng-Cr3871-10kU | Creative Biolabs | 10 kU | EUR 505.2 |
|
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Milk. The purity is detected by salt extraction and delipidization following high speed centrifugation. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|||
Sperm Associated Antigen 11A (SPAG11A) Antibody |
|||
| abx238139-100ug | Abbexa | 100 ug | EUR 661.2 |
Sperm Associated Antigen 11A (SPAG11A) Antibody |
|||
| 20-abx115757 | Abbexa |
|
|
Sperm Associated Antigen 11A (SPAG11A) Antibody |
|||
| abx025940-400ul | Abbexa | 400 ul | EUR 627.6 |
Sperm Associated Antigen 11A (SPAG11A) Antibody |
|||
| abx025940-80l | Abbexa | 80 µl | EUR 343.2 |
Sperm Associated Antigen 11A (SPAG11A) Antibody |
|||
| 20-abx124930 | Abbexa |
|
|
MPO Antigen |
|||
| E61A00501 | EnoGene | 1mg | EUR 1230 |
HAV Antigen |
|||
| E61H00101 | EnoGene | 1mg | EUR 733.2 |
HBS Antigen |
|||
| E61H00301 | EnoGene | 1mg | EUR 374.4 |
HBS Antigen |
|||
| E61H00302 | EnoGene | 1mg | EUR 374.4 |
HBe Antigen |
|||
| E61H00501 | EnoGene | 1mg | EUR 463.2 |
HBc Antigen |
|||
| E61H00701 | EnoGene | 1mg | EUR 463.2 |
AFP Antigen |
|||
| E62C002 | EnoGene | 20ug | EUR 458.4 |
HCG Antigen |
|||
| E62C004 | EnoGene | 100ug | EUR 458.4 |
CEA Antigen |
|||
| E62C010 | EnoGene | 20ug | EUR 458.4 |
CK8 Antigen |
|||
| E62C02001 | EnoGene | 20ug | EUR 458.4 |
CRP Antigen |
|||
| E64C00501 | EnoGene | 1mg | EUR 840 |
CRP Antigen |
|||
| E64C00502 | EnoGene | 1mg | EUR 840 |
CD9 Antigen |
|||
| E6TA00101 | EnoGene | 0.1mg | EUR 411.6 |
BSA Antigen |
|||
| IM112 | Cygnus Technologies | 1 ml | EUR 342 |
|
Description: BSA Antigen by Cygnus Technologies is available in Europe via Gentaur. |
|||
HSA Antigen |
|||
| IM118 | Cygnus Technologies | 1 ml | EUR 342 |
|
Description: HSA Antigen by Cygnus Technologies is available in Europe via Gentaur. |
|||
CDV Antigen |
|||
| VAng-Lsx0016-1mg | Creative Biolabs | 1 mg | EUR 1688.4 |
|
Description: Canine Distemper Virus Antigen from SL-29 cells. |
|||
Gastrointestinal Cancer Antigen (CA 19-9), antigen grade |
|||
| CA1991-N-10 | Alpha Diagnostics | 10 KU | EUR 634.8 |
Inactivated Coxsackievirus A16 Antigen |
|||
| VAng-Lsx0079-1mL | Creative Biolabs | 1 mL | EUR 700.8 |
|
Description: Coxsackievirus A16, natural antigen. |
|||
S100 Antigen |
|||
| E62B003 | EnoGene | 20ug | EUR 458.4 |
CA50 Antigen |
|||
| E62C009 | EnoGene | 10KU | EUR 458.4 |
CK18 Antigen |
|||
| E62C02101 | EnoGene | 20ug | EUR 458.4 |
CK20 Antigen |
|||
| E62C02201 | EnoGene | 20ug | EUR 458.4 |
GP73 antigen |
|||
| E62C02701 | EnoGene | 20ug | EUR 458.4 |
TP17 Antigen |
|||
| E62H00701 | EnoGene | 100ug | EUR 458.4 |
TP47 Antigen |
|||
| E62H00702 | EnoGene | 100ug | EUR 458.4 |
cTnI antigen |
|||
| E64C00101 | EnoGene | 100ug | EUR 508.8 |
cTnI antigen |
|||
| E64C00102 | EnoGene | 100ug | EUR 733.2 |
cTnC antigen |
|||
| E64C01301a | EnoGene | 20ug | EUR 411.6 |
sST2 antigen |
|||
| E64C01501 | EnoGene | 20ug | EUR 411.6 |
PAPP Antigen |
|||
| E64D00101 | EnoGene | 100ug | EUR 1425.6 |
PAPP Antigen |
|||
| E64D00102 | EnoGene | 1mg | EUR 5910 |
CD63 Antigen |
|||
| E6TA00102 | EnoGene | 0.1mg | EUR 411.6 |
CD81 Antigen |
|||
| E6TA00103 | EnoGene | 0.1mg | EUR 411.6 |
Cancer Antigen CEA Antigen (Human Metastatic Liver) |
|||
| VAng-Wyb8645-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Carcinoembryonic Antigen, Antigen Grade, Cancer antigen from Human Metastatic Liver, 5.5 mg/mL. |
|||
CA242 Antigen |
|||
| E62C00601 | EnoGene | 50KU | EUR 2078.4 |
CA242 Antigen |
|||
| E62C00602 | EnoGene | 10KU | EUR 458.4 |
CA199 Antigen |
|||
| E62C007 | EnoGene | 10KU | EUR 458.4 |
CA199 Antigen |
|||
| E62C00701 | EnoGene | 50KU | EUR 1180.8 |
CA199 Antigen |
|||
| E62C00702 | EnoGene | 50KU | EUR 1620 |
CA125 Antigen |
|||
| E62C011 | EnoGene | 10KU | EUR 458.4 |
CA153 Antigen |
|||
| E62C012 | EnoGene | 10KU | EUR 458.4 |
EpCAM Antigen |
|||
| E64B00107 | EnoGene | 0.1mg | EUR 411.6 |
HSP70 Antigen |
|||
| E6TA00104 | EnoGene | 0.1mg | EUR 411.6 |
CD133 Antigen |
|||
| E6TA00105 | EnoGene | 0.1mg | EUR 411.6 |
CD32a Antigen |
|||
| E6TA00106 | EnoGene | 0.1mg | EUR 411.6 |
Cancer Antigen CA-125 Antigen (Human Adenocarcinoma) |
|||
| VAng-Wyb8642-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: CA-125, Calibrator Grade, Cancer antigen from Human Adenocarcinoma, 500 kIU / mL. |
|||
S100BB Antigen |
|||
| E62B00201 | EnoGene | 20ug | EUR 458.4 |
S100BB Antigen |
|||
| E62B00202 | EnoGene | 20ug | EUR 458.4 |
Giardia Trophozoite Recombinant antigen antigen 34 kDa |
|||
| 00321-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280 |
|||
Giardia Trophozoite Recombinant antigen antigen 34 kDa |
|||
| 00321-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280 |
|||
Cancer Antigen 19-9 Antigen (Liver Carcinoma) (High purity) |
|||
| VAng-Cr3874-25kU | Creative Biolabs | 25 kU | EUR 1033.2 |
|
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. |
|||
S100A1B Antigen |
|||
| E62B00101 | EnoGene | 20ug | EUR 458.4 |
S100A1B Antigen |
|||
| E62B00102 | EnoGene | 20ug | EUR 458.4 |
Insulin Antigen |
|||
| E64I001 | EnoGene | 1mg | EUR 418.8 |
Insulin Antigen |
|||
| IM121 | Cygnus Technologies | 1 ml | EUR 342 |
|
Description: Insulin Antigen by Cygnus Technologies is available in Europe via Gentaur. |
|||
Ferritin Antigen |
|||
| E62C013 | EnoGene | 100ug | EUR 458.4 |
Ferritin Antigen |
|||
| E62C01304 | EnoGene | 100ug | EUR 458.4 |
Copeptin antigen |
|||
| E64C01601 | EnoGene | 100ug | EUR 411.6 |
Cancer Antigen AFP Antigen (Human hepatocellular carcinoma) |
|||
| VAng-Wyb8625-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Alpha Fetoprotein, Antigen Grade, Cancer antigen from human hepatocellular carcinoma, 2.93 mg/mL. |
|||
HHV-4 recombinant EA antigen. Region: 306-390aa |
|||
| 00213-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
Description: HHV-4 recombinant EA antigen. Region: 306-390aa |
|||
Rotavirus Antigen |
|||
| DAGA-258 | Creative Diagnostics | 1 ml dry ice | EUR 873.6 |
Rat Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E02C2138-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Rat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E02C2138-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Rat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E02C2138-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Rat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E07C2138-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E07C2138-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E08C2138-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Canine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E08C2138-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Canine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E08C2138-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Canine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E07C2138-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Cancer Antigen 15-3 MUC 1 Antigen (Human Ascites Fluid) |
|||
| VAng-Cr3872-10kU | Creative Biolabs | 10 kU | EUR 1363.2 |
|
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Ascites Fluid. |
|||
GPA33 Antibody / Cell surface A33 antigen |
|||
| F55008-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
|
Description: GPA33 is a cell surface antigen that is expressed in greater than 95% of human colon cancers. It may play a role in cell-cell recognition and signaling. |
|||
GPA33 Antibody / Cell surface A33 antigen |
|||
| F55008-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
|
Description: GPA33 is a cell surface antigen that is expressed in greater than 95% of human colon cancers. It may play a role in cell-cell recognition and signaling. |
|||
HHV-4 recombinant p18 antigen Region: 1-119aa |
|||
| 00211-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
Description: HHV-4 recombinant p18 antigen Region: 1-119aa |
|||
Goat Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E06C2138-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Goat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E06C2138-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Goat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Cancer/testis antigen 47A(CT47A1) ELISA kit |
|||
| E06C2138-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Goat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC800883-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680 conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC800883-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680 conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC810883-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680R conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC810883-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680R conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC940883-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF594 conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC940883-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF594 conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC700883-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF770 conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC700883-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF770 conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC880883-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF488A conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC880883-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF488A conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC050883-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF405M conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC050883-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF405M conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC040883-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF405S conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC040883-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF405S conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC400883-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF640R conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNC400883-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF640R conjugate, Concentration: 0.1mg/mL |
|||
PSA (Prostate Specific Antigen)(A67-B/E3) Antibody |
|||
| BNCB0883-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Here we describe strategies for the development of such fluorescent reporter M. tuberculosis strains, and their use together with confocal microscopy and movement cytometry approaches for single bacterium-level analyses of M. tuberculosis physiology and M. tuberculosis-host interactions.
